Literature DB >> 33747370

Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing.

Xingang Yao1,2, Pin Lyu1, Kyung Yoo1, Manish Kumar Yadav1, Ravi Singh3, Anthony Atala1, Baisong Lu1.   

Abstract

Transient delivery of CRISPR-based genome editing effectors is important to reduce off-target effects and immune responses. Recently extracellular vesicles (EVs) have been explored for Cas9 ribonucleoprotein (RNP) delivery. However, lack of mechanisms to enrich RNPs into EVs limited the efficiency of EVs as a RNP delivery vehicle. Here we describe a mechanism to actively enrich RNPs into EVs. We used the specific interaction between RNA aptamer and aptamer-binding protein (ABP) to enrich RNPs into EVs. We inserted RNA aptamer com into single guide RNA (sgRNA), and fused com-binding ABP Com to both termini of tetraspan protein CD63 that is abundant in exosomes. We found that the Com/com interaction enriched Cas9 and adenine base editor (ABE) RNPs into EVs, via forming a three-component complex including CD63-Com fusion protein, com-modified sgRNA and Cas9 or ABE. The RNP enriched EVs are efficient in genome editing and transiently expressed. The system is capable of delivering RNPs targeting multiple loci for multiplex genome editing. In addition, Cas9 from different species can be used together. The EV-delivered RNPs are active in vivo. The data show that the aptamer and ABP interactions can be utilized to actively enrich RNPs into EVs for improved genome editing efficiency and safety.
© 2021 The Authors. Journal of Extracellular Vesicles published by Wiley Periodicals, LLC on behalf of the International Society for Extracellular Vesicles.

Entities:  

Keywords:  CD63; CRISPR/Cas9; adenine base editor; aptamer; aptamer‐binding protein; delivery; extracellular vesicle; ribonucleoprotein

Mesh:

Substances:

Year:  2021        PMID: 33747370      PMCID: PMC7962171          DOI: 10.1002/jev2.12076

Source DB:  PubMed          Journal:  J Extracell Vesicles        ISSN: 2001-3078


  43 in total

1.  CRISPResso2 provides accurate and rapid genome editing sequence analysis.

Authors:  Kendell Clement; Holly Rees; Matthew C Canver; Jason M Gehrke; Rick Farouni; Jonathan Y Hsu; Mitchel A Cole; David R Liu; J Keith Joung; Daniel E Bauer; Luca Pinello
Journal:  Nat Biotechnol       Date:  2019-03       Impact factor: 54.908

2.  Autolytic processing of dimeric plant virus satellite RNA.

Authors:  G A Prody; J T Bakos; J M Buzayan; I R Schneider; G Bruening
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

3.  Differential fates of biomolecules delivered to target cells via extracellular vesicles.

Authors:  Masamitsu Kanada; Michael H Bachmann; Jonathan W Hardy; Daniel Omar Frimannson; Laura Bronsart; Andrew Wang; Matthew D Sylvester; Tobi L Schmidt; Roger L Kaspar; Manish J Butte; A C Matin; Christopher H Contag
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

4.  Generation of hypoimmunogenic human pluripotent stem cells.

Authors:  Xiao Han; Mengning Wang; Songwei Duan; Paul J Franco; Jennifer Hyoje-Ryu Kenty; Preston Hedrick; Yulei Xia; Alana Allen; Leonardo M R Ferreira; Jack L Strominger; Douglas A Melton; Torsten B Meissner; Chad A Cowan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-30       Impact factor: 11.205

5.  Delivery of an Artificial Transcription Regulator dCas9-VPR by Extracellular Vesicles for Therapeutic Gene Activation.

Authors:  Duško Lainšček; Lucija Kadunc; Mateja Manček Keber; Iva Hafner Bratkovič; Rok Romih; Roman Jerala
Journal:  ACS Synth Biol       Date:  2018-12-07       Impact factor: 5.110

6.  A cell line expressing vesicular stomatitis virus glycoprotein fuses at low pH.

Authors:  R Z Florkiewicz; J K Rose
Journal:  Science       Date:  1984-08-17       Impact factor: 47.728

7.  Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles.

Authors:  J Reiser; G Harmison; S Kluepfel-Stahl; R O Brady; S Karlsson; M Schubert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

8.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

9.  Cas-analyzer: an online tool for assessing genome editing results using NGS data.

Authors:  Jeongbin Park; Kayeong Lim; Jin-Soo Kim; Sangsu Bae
Journal:  Bioinformatics       Date:  2016-08-24       Impact factor: 6.937

View more
  22 in total

1.  Serum extracellular vesicles for delivery of CRISPR-CAS9 ribonucleoproteins to modify the dystrophin gene.

Authors:  Nathalie Majeau; Annabelle Fortin-Archambault; Catherine Gérard; Joël Rousseau; Pouiré Yaméogo; Jacques P Tremblay
Journal:  Mol Ther       Date:  2022-05-26       Impact factor: 12.910

2.  Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment.

Authors:  Yujie Liang; Xiao Xu; Limei Xu; Zoya Iqbal; Kan Ouyang; Huawei Zhang; Chunyi Wen; Li Duan; Jiang Xia
Journal:  Theranostics       Date:  2022-06-21       Impact factor: 11.600

Review 3.  CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease.

Authors:  Mujeeb Ur Rahman; Muhammad Bilal; Junaid Ali Shah; Ajeet Kaushik; Pierre-Louis Teissedre; Małgorzata Kujawska
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

4.  Delivery of engineered extracellular vesicles with miR-29b editing system for muscle atrophy therapy.

Authors:  Rui Chen; Weilin Yuan; Yongjun Zheng; Xiaolan Zhu; Bing Jin; Tingting Yang; Yuwei Yan; Wanru Xu; Hongjian Chen; Juan Gao; Guoping Li; Priyanka Gokulnath; Gururaja Vulugundam; Jin Li; Junjie Xiao
Journal:  J Nanobiotechnology       Date:  2022-06-27       Impact factor: 9.429

Review 5.  CRISPR/Cas9: Principle, Applications, and Delivery through Extracellular Vesicles.

Authors:  Katarzyna Horodecka; Markus Düchler
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

6.  Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing.

Authors:  Xingang Yao; Pin Lyu; Kyung Yoo; Manish Kumar Yadav; Ravi Singh; Anthony Atala; Baisong Lu
Journal:  J Extracell Vesicles       Date:  2021-03-16

7.  Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis.

Authors:  Chengqi Yan; Jing Chen; Cheng Wang; Meng Yuan; Yu Kang; Zihan Wu; Wenqing Li; Guolei Zhang; Hans-Günther Machens; Yuval Rinkevich; Zhenbing Chen; Xiaofan Yang; Xiang Xu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 8.  Targeting Cancer with CRISPR/Cas9-Based Therapy.

Authors:  Katarzyna Balon; Adam Sheriff; Joanna Jacków; Łukasz Łaczmański
Journal:  Int J Mol Sci       Date:  2022-01-05       Impact factor: 5.923

9.  Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins.

Authors:  Samagya Banskota; Aditya Raguram; Susie Suh; Samuel W Du; Jessie R Davis; Elliot H Choi; Xiao Wang; Sarah C Nielsen; Gregory A Newby; Peyton B Randolph; Mark J Osborn; Kiran Musunuru; Krzysztof Palczewski; David R Liu
Journal:  Cell       Date:  2022-01-11       Impact factor: 66.850

Review 10.  Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine.

Authors:  Lijun Chen; Jingjing Qu; Quanhui Mei; Xin Chen; Yangxin Fang; Lu Chen; Yifei Li; Charlie Xiang
Journal:  Stem Cell Res Ther       Date:  2021-08-03       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.